跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 96,400 条关于
“papillary thyroid cancer”
全部
96,400
临床试验
78,224
药物
2,252
机构
1,102
资讯
14,822
去年
FORE Biotherapeutics Reports Durable Clinical Benefit with Plixorafenib in BRAF-Altered Thyroid Cancers
2个月前
Neoadjuvant Lenvatinib Shrinks Thyroid Tumor and Improves Surgical Outcomes in Advanced Thyroid Cancer
上个月
Dabrafenib Plus Trametinib Significantly Improves PFS in BRAF V600E-Positive Advanced Thyroid Cancer
去年
BRAF p.V600E Mutation Shows Limited Prognostic Value in Papillary Thyroid Cancer Risk Stratification
去年
SY-5007 Demonstrates Promising Efficacy in RET-Altered Solid Tumors: Phase 1 Trial Results
去年
Ferroptosis Emerges as Novel Therapeutic Target in Cancer Treatment and Immunotherapy
2个月前
Nuvectis In-Licenses Two Clinical-Stage Assets from Haisco, Transforming into Late-Stage Biopharma with Oral Factor B and Paradox-Breaker BRAF Inhibitors
2个月前
Vivos Receives FDA IDE Approval for First-in-Human RadioGel Trial in Non-Resectable Papillary Thyroid Carcinoma
3个月前
Vivos Inc. Receives FDA IDE Approval to Initiate First-in-Human Study of RadioGel® for Papillary Thyroid Carcinoma
去年
Targeted Therapy and Immunotherapy Combination Shows Promise in Anaplastic Thyroid Carcinoma
第 1 页,共 1483 页
上一页
下一页